UMLT18037 / Mayo MC17C1 / Richard Dunne
Research Question:
What are the side effects of ketoconazole and how well it works in treating participants
with ongoing EGFR inhibitor-induced rash?
Basic Study Information
Purpose:
This early phase I trial studies the side effects of ketoconazole and how well it
works in treating participants with ongoing EGFR inhibitor-induced rash. Ketoconazole
may reduce the symptoms related to EGFR inhibitor therapy and improve EGFR inhibitor-induced
rash.
Location: University of Rochester Medical Center
Study Reference #: UMLT18037
Lead Researcher (Principal Investigator)
Lead Researcher:
Richard Dunne
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search